EVERSANA

Commercialization services company whose NAVLIN platform combines data, software, and AI for global pricing and market access.

EVERSANA, headquartered in Chicago, Illinois, is a commercialization services company for the life sciences industry whose NAVLIN platform combines data, software, and analytics to answer global price and market-access questions for pharmaceutical companies. This Atlas listing covers the NAVLIN price and market-access platform. EVERSANA documents ISO 27001 security certification on the NAVLIN product page; other certifications referenced elsewhere apply to separate EVERSANA business units and are not attributed here.

Headquarters
Chicago, United States
Compliance
ISO 27001
Deployment options
cloud
Website
https://www.navlin.com
LinkedIn
https://www.linkedin.com/company/eversana

Categories

AI Use Cases

  • Market Access & HTA Strategy

Vendor Scorecard

57% — Partial coverage. Coverage score — how completely Atlas documents EVERSANA across 7 buyer-evaluation areas. Reflects available Atlas data, not solution quality.

Compliance & Validation — Documented

ISO 27001

Deployment & Hosting — Documented

cloud

Pricing Transparency — Not documented by Atlas

Ask the vendor: What is your pricing model, and what drives total cost of ownership?

Implementation & Onboarding — Not documented by Atlas

Ask the vendor: What is a realistic implementation timeline, and what onboarding support is included?

Organization & Role Fit — Documented

Mid-Size Biotech, Large Pharma, Top 20 Pharma, Commercial, Medical Affairs

Solution Scope — Documented

Market Access Analytics

Company Viability — Not documented by Atlas

Ask the vendor: What is your funding position, team size, and customer traction?

Always ask the vendor

Not captured in Atlas data — confirm directly. Excluded from the score above.

Data Rights & IP

Who owns model outputs? Is our proprietary data used to train models others can access, and where does our data reside?

Model Credibility & Explainability

Can you share validation studies or benchmarks, explain how the model reaches its conclusions, and describe how bias and drift are monitored?

Questions to Ask This Vendor

  • Which NAVLIN modules and datasets cover our markets and therapeutic area?
  • How current is the global pricing and access intelligence?
  • Can you share the ISO 27001 certificate and its scope under NDA?
  • How does NAVLIN integrate with our existing pricing and access workflows?